UPC_CFI_395/2023

REMOTE MONITORING OF ANALYTE MEASUREMENTS

InfringementMain Infringement ActionParis LDInfringementCase Closed

Overview Decisions Documents Timeline

Parties

Claimants

Dexcom Inc.(Dexcom Group)

Reps: Anne-Charlotte le Bihan

Respondents

Abbott Laboratories(Abbott Group)
Abbott Diabetes Care Inc.(Abbott Group)
Abbott France(Abbott Group)
Abbott(Abbott Group)
Abbott B.V.(Abbott Group)
Abbott s.r.l.(Abbott Group)
Abbott Scandinavia Aktiebolag(Abbott Group)
Abbott Oy(Abbott Group)
Abbott Gesellschaft m.b.H.(Abbott Group)
Abbott Laboratories A/S(Abbott Group)
Abbott GmbH(Abbott Group)
Abbott Diagnostics GmbH(Abbott Group)
Abbott Logistics B.V.(Abbott Group)
Newyu,Inc.(Abbott Group)

Reps: Christian Dekoninck; François Pochart

Judges

French-seated division — individual judges anonymized.

Panel member (anonymized)
Panel member (anonymized)
Panel member (anonymized)
Panel member (anonymized)

Patents

EP3831282
EP 3 831 282

CPC codes: A61B5/7282, A61B5/7465, G16H40/20, H04L67/12, G16H50/70, A61B5/145, G16H40/63, G16H50/20, A61B5/0015, A61B5/0004, A61B5/14532, A61B5/14546…

Technology area: Medical Devices · CGM

Sector: Healthcare Informatics

Outcome

Procedural onlyProcedural only (no substantive ruling yet)

Filed: Oct 30, 2023

First decided: Feb 12, 2024

Language: English

Open on UPC Registry